But considering the critical role of EGFR in tumor cell proliferation and survival, EGFR inhibitors may help prevent tumor recurrence or even inhibit the proliferation of undiagnosed micrometastases or the activation of dormant metastases. The gene discussed is EGFR; the disease is neoplasm.